Dimethylindanoylindole isomers revealed different pharmacological profiles at CB1 and CB2 cannabinoid receptors

2025 · doi:10.1101/2025.09.16.676463
preprint OA: closed CC-BY-NC-ND-4.0
📄 Open PDF Full text JSON View at publisher

Abstract

Synthetic cannabinoid receptor agonists (SCRAs) represent one of the most rapidly growing classes of novel psychoactive substances (NPS) and exhibit higher efficacy and potency at CB1 and CB2 cannabinoid receptors (CB1 and CB2) compared to Δ 9 -tetrahydrocannabinol, contributing to distinct adverse effects absent in cannabis use. The indole-based SCRAs GBD-002 and GBD-003, incorporating 2,2-dimethylindane, differ by a single substituent position yet display markedly different receptor binding profiles. We evaluated both the GBD-002/GBD-003 pair and an analogous structural isomer pair using bioluminescence resonance energy transfer (BRET) assays to assess key CB1 and CB2 transducer pathways. Site-directed mutagenesis characterized contributions of non-conserved residues between CB1 and CB2 and aromatic residues on CB1 transmembrane helix 2 (TM2). This study provided insights into the molecular determinants of cannabinoid receptor selectivity and efficacy.
Full text 1,053 characters · extracted from oa-doi-fallback · click to expand
Abstract Synthetic cannabinoid receptor agonists (SCRAs) represent one of the most rapidly growing classes of novel psychoactive substances (NPS) and exhibit higher efficacy and potency at CB1 and CB2 cannabinoid receptors (CB1 and CB2) compared to Δ9-tetrahydrocannabinol, contributing to distinct adverse effects absent in cannabis use. The indole-based SCRAs GBD-002 and GBD-003, incorporating 2,2-dimethylindane, differ by a single substituent position yet display markedly different receptor binding profiles. We evaluated both the GBD-002/GBD-003 pair and an analogous structural isomer pair using bioluminescence resonance energy transfer (BRET) assays to assess key CB1 and CB2 transducer pathways. Site-directed mutagenesis characterized contributions of non-conserved residues between CB1 and CB2 and aromatic residues on CB1 transmembrane helix 2 (TM2). This study provided insights into the molecular determinants of cannabinoid receptor selectivity and efficacy. Competing Interest Statement The authors have declared no competing interest.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00
unpaywall
last seen: 2026-05-24T02:00:01.246996+00:00
License: CC-BY-NC-ND-4.0